ArticleCancers2020

Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients.

Anne Tranberg Madsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.